NYXH News

Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands

Publication relating to transparency notifications

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

Informations sur le nombre total de droits de vote et d'actions

Information on the total number of voting rights and shares

Nyxoah Obtient des Engagements de Financement pouvant atteindre U.S. $77 Millions pour Supporter la Commercialisation de Genio aux États-Unis

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio